Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial
Kerstin Blom1, Susanna Jernelöv2, Martin Kraepelien1
1Karolinska Institutet, Department of Clinical Neuroscience, Division of Psychiatry, Stockholm, Sweden.
Study Objectives:
To compare treatment effects when patients with insomnia and depression receive treatment for either insomnia or depression.
Design:
A 9-w randomized controlled trial with 6- and 12-mo follow-up.
Setting:
Internet Psychiatry Clinic, Stockholm, Sweden.
Participants:
Forty-three adults in whom comorbid insomnia and depression were diagnosed, recruited via media and assessed by psychiatrists.
Interventions:
Guided Internet-delivered cognitive behavior therapy (ICBT) for either insomnia or depression.
Measurements And Results:
Primary outcome measures were symptom self-rating scales (Insomnia Severity Index [ISI] and the Montgomery Åsberg Depression Rating Scale [MADRS-S]), assessed before and after treatment with follow-up after 6 and 12 mo. The participants' use of sleep medication and need for further treatment after completion of ICBT was also investigated. The insomnia treatment was more effective than the depression treatment in reducing insomnia severity during treatment (P = 0.05), and equally effective in reducing depression severity. Group differences in insomnia severity were maintained during the 12-mo follow-up period. Post treatment, participants receiving treatment for insomnia had significantly less self-rated need for further insomnia treatment (P < 0.001) and used less sleep medication (P < 0.05) than participants receiving treatment for depression. The need for depression treatment was similar in both groups.
Conclusions:
In this study, Internet-delivered treatment with cognitive behavior therapy (ICBT) for insomnia was more effective than ICBT for depression for patients with both diagnoses. This indicates, in line with previous research, that insomnia when comorbid with depression is not merely a symptom of depression, but needs specific treatment.
Trial Registration:
The trial was registered at Clinicaltrials.gov, registration ID: NCT01256099.
Related Concept Videos
Management of Insomnia
Antidepressant Drugs: MAOIs and Other Agents
Insomnia
Multiple factors contribute...
Blind Procedures
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
The Placebo Effect

